This stock is poised for it's next leg up with the FDA approval of its syngergraft coming by the end of the month. Check it out and as always, conduct your own due diligence. I have made a decent return from 7$, I think it is still under valued based upon the the products and contracts they currently have with the government. Good luck, take care.
Also, if anyone else is familiar with this company or has insight opinons regarding their future growth, please feel free to reply.
Matt
Also, if anyone else is familiar with this company or has insight opinons regarding their future growth, please feel free to reply.
Matt
Last edited:
